Nikkei 225 (N225, Tokyo) closes below 63,500 points on July 25, 2026
Pending
✦ AI-generated prediction
Published on 24. July 2026
·
Predicted for 25. July 2026
·
Based on: Ongoing Event
The Nikkei 225 fell ~2.73% on July 24, 2026 to close at 64,611 – well below its June 2026 all-time high of 73,007. Drivers: Tesla's Q2 2026 disaster (GAAP EPS $0.32 vs. $0.53 consensus; net loss –$4.75bn; stock –14.5% AH), broad tech sector pressure and WTI crude at $90.56/barrel (+25.9% MTD), which is structurally negative for energy-import-dependent Japan. A further 1.7% decline on July 25 would push the index to 63,500 or below. No Polymarket anchor available; own estimate 33% (base case: slight stabilisation after dramatic –2.73% day).
Data basis for this prediction
- Nikkei 225 Schlusskurs 24.07.2026: 64.611 (–2,73 %), Trading Economics
- Nikkei 225 Juni-2026-ATH: 73.007 Punkte, Trading Economics
- Tesla Q2 2026: GAAP-EPS 0,32 USD (Konsens 0,53 USD), Nettoverlust –4,75 Mrd. USD, Aktie –14,5 % AH – Teslarati / Electrek
- WTI-Rohöl 24.07.2026: 90,56 USD/Barrel (+25,92 % MTD), Trading Economics / Forbes Advisor
Note: This is an AI-generated statistical forecast for entertainment and information purposes. It does not constitute investment advice or a recommendation to buy or sell any financial instrument.
Verdict: Pending
This prediction is still open. It will be evaluated automatically against real-world sources after its due date.
📈 Economy
✦ AI
The PDUFA date for iberdomide (combination with daratumumab + dexamethasone, EXCALIBER-RRMM Phase 3 study) is August 17, 2026. BMS received both Breakthrough Therapy and Priority Review designation – both signals of strong regulatory support. The FDA historically approves ~83–87% of applications reaching a PDUFA date; with Breakthrough Therapy designation the rate is even higher (>90%). No negative Advisory Committee signal is known. Cassandra estimates the approval probability at 78% (slight discount vs historical average for a complex combination therapy).
📈 Economy
✦ AI
The Hang Seng fell ~1.12% on July 24, 2026 to 24,929 (YTD –2.69% YoY, but +6.68% MTD). Hong Kong tech stocks (Alibaba, Tencent, Meituan) are particularly vulnerable to global tech risk-aversion following the Tesla shock. Additional pressure from geopolitical tensions in the Taiwan Strait (PLA exercises anticipated in August) and the oil price shock. To fall below 24,500 would require a further –1.7% – possible but not the base case after an already weak session. No Polymarket anchor; own estimate 30%.
📈 Economy
✦ AI
The S&P 500 closed at 7,408.30 on July 23, 2026 (–1.21%). On July 24, the index is expected to fall another 1.5–2% due to the Tesla shock (–14.5% AH; ~2% S&P weight) and broad tech selling, pushing it to ~7,200–7,300. On July 25, two stabilising factors are active: the June 2026 US Core PCE release (08:30 EDT; Cassandra open: ≥3.0%) and anticipation of strong Big Tech earnings the week of July 28 (Meta, Microsoft, Apple, Amazon already predicted). Stabilisation above 7,250 is the base case. Kalshi shows 77% probability of unchanged Fed rate on July 29 – no immediate rate-shock risk. Own estimate: 62%.